New Alzheimer's Drug; Tax Inequality

There's excitement — and controversy — surrounding Biogen's new Alzheimer's drug. What are doctors saying? Penn Memory Center's Dr. Jason Karlawish and Lenox Hill Hospital's Dr. Gayatri Devi share their thoughts. And, ProPublica revealed a trove of tax records showing the megarich pay next to nothing in income taxes. Robert McClelland of the Urban-Brookings Tax Policy Center weighs in. That and more, in hour two of Here & Now's June 10, 2021, full broadcast. You can find more at hereandnow.org — and follow us on Twitter, Instagram or join the conversation on Facebook.